Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
about
Full Expression of Cardiomyopathy Is Partly Dependent on B-Cells: A Pathway That Involves Cytokine Activation, Immunoglobulin Deposition, and Activation of Apoptosis.Peripartum cardiomyopathy: A puzzle closer to solution.Impaired thymic export and apoptosis contribute to regulatory T-cell defects in patients with chronic heart failureThe favorable IFNL3 genotype escapes mRNA decay mediated by AU-rich elements and hepatitis C virus-induced microRNAs.Fatal giant cell myocarditis in a patient with multiple autoimmune disordersIncreased frequency of follicular helper T cells in mice viral myocarditis is relevant with anti-ANT antoantibody.Mononuclear cell secretome protects from experimental autoimmune myocarditisAdvances in monoclonal antibody application in myocarditis.Inflammation as a therapeutic target in heart failure? A scientific statement from the Translational Research Committee of the Heart Failure Association of the European Society of Cardiology.Anti-heart autoantibodies in familial dilated cardiomyopathy.Effects of preexisting autoimmunity on heart graft prolongation after donor-specific transfusion and anti-CD154.The clinical significance of anti-beta-1 adrenergic receptor autoantibodies in cardiac disease.The clinical and diagnostic significance of anti-myosin autoantibodies in cardiac disease.Acute myocarditis in children.Drug-like actions of autoantibodies against receptors of the autonomous nervous system and their impact on human heart functionCurrent treatment options in (peri)myocarditis and inflammatory cardiomyopathy.Viral myocarditis: from experimental models to molecular diagnosis in patients.Immune-mediated and autoimmune myocarditis: clinical presentation, diagnosis and management.Increased Mobilization of CD45+CD34+VLA-4+ Cells in Acute Viral Myocarditis Induced by Coxsackievirus B3.A new monoclonal antibody (Cox mAB 31A2) detects VP1 protein of coxsackievirus B3 with high sensitivity and specificity.Changes in serum cardiac myosin light chain 1 levels in children with fulminant myocarditis during continuous blood purification.Cardiac involvements in myasthenia gravis associated with anti-Kv1.4 antibodies.Lymphocytes at the Heart of Wound Healing.Roles of Host Immunity in Viral Myocarditis and Dilated Cardiomyopathy.Myocarditis
P2860
Q31037009-7F88F0C3-B99B-4E40-A2A7-72BB1E98DDD1Q33358118-9A1E0A3A-385A-4F60-BFAB-2DC3AB32A776Q34026055-FDC27EA0-20AB-42B5-AC7C-5B4A7475C44AQ34281428-24A6B4CF-BCA4-49DB-83B9-18150DE4A08DQ34530643-84B8DB7F-AF1F-449C-B5E1-410B819AC1CFQ35147469-F6DFB32E-1A4F-4913-AFC0-468EBA47A26FQ35176487-AEA16B22-444A-4DFB-98C5-4A56BE1EF3D6Q37076590-80AAEC2D-C42F-45C9-89D4-F38247E5BEC9Q37090971-AB6BFC4E-747F-4D68-AC29-959DB6D98425Q37264376-85742E99-C8DE-4384-86C7-80596D2B4CEFQ37423395-28FE1F68-14C0-4E70-AD6E-F89790187952Q37824303-2E904D58-C9B5-4B91-93FC-630F5DE33AF5Q37826114-260C16D8-1E5A-4BF5-8B62-68CB2A278802Q37895688-78CC6AE7-CDE1-4D0E-9335-C8588F41B40AQ37973384-E6DDC493-3E1B-4186-9790-AF59030DA082Q38045203-93505C85-9B96-4353-870E-FC5B3EBE775CQ38052447-139BAE88-DA62-49DC-9030-179C6FB78386Q38056870-876094E2-0471-4351-9EAD-9D667A4F63B7Q40060113-B33EC45F-4057-4C0A-8885-32CB2AB35D27Q40483810-39FFC257-7232-4C0A-A7E4-35BC2A0D41AFQ47901663-79D95543-C5EA-4B3D-907C-CCDF6759D8E0Q50856529-27ED0E99-5993-48ED-B845-FC728FA992D2Q50913483-411B76D3-A742-47F9-8482-7D3963D404E6Q55166882-03F91D7D-53B7-4307-88B9-82A0573CB293Q56912295-92BAE3BA-CCAB-41A0-887F-0BFAEF886D5F
P2860
Clinical implications of anti-heart autoantibodies in myocarditis and dilated cardiomyopathy.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on February 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Clinical implications of anti- ...... is and dilated cardiomyopathy.
@en
Clinical implications of anti- ...... is and dilated cardiomyopathy.
@nl
type
label
Clinical implications of anti- ...... is and dilated cardiomyopathy.
@en
Clinical implications of anti- ...... is and dilated cardiomyopathy.
@nl
prefLabel
Clinical implications of anti- ...... is and dilated cardiomyopathy.
@en
Clinical implications of anti- ...... is and dilated cardiomyopathy.
@nl
P2093
P2860
P1433
P1476
Clinical implications of anti- ...... is and dilated cardiomyopathy.
@en
P2093
Alida L P Caforio
Annalisa Vinci
Francesco Tona
Gaetano Thiene
Greta Dequal
Luciano Daliento
Sabino Iliceto
Stefania Bottaro
P2860
P356
10.1080/08916930701619235
P577
2008-02-01T00:00:00Z